COPD对非小细胞肺癌临床特点及病理类型的影响(4)
[11]Huang JY，Jian ZH，Nfor ON，Ku WY，Ko PC，Lung CC，HoCC，Pan HH，Huang CY，Liang YC，Liaw YP.The effects ofpulmonary diseases on histologic types of lung cancer in bothsexes：a population-based study in Taiwan.BMC Cancer，2015，15：834.
[12]Hashimoto N，Matsuzaki A，Okada Y，Imai N，Iwano S，WakaiK，Imaizumi K，Yokoi K，Hasegawa Y.Clinical impact ofprevalence and severity of COPD on the decision-making processfor therapeutic management of lung cancer patients.BMC PulmMed，2014，14：14.
, 百拇医药
[13]Omote N，Hashimoto N，Morise M，Sakamoto K，Miyazaki S，Ando A，Nakahara Y，Hasegawa Y.Impact of mild to moderateCOPD on feasibility and prognosis in non-small cell lung cancerpatients who received chemotherapy.Int J Chron ObstructPulmon Dis，2017，12：3541-3547.
[14]Liu S，Zhang M，Yang L，Li Y，Wang L，Huang Z，Wang L，Chen Z，Zhou M.Prevalence and patterns of tobacco smokingamong Chinese adult men and women：findings of the 2010national smoking survey.Epidemiol Community Health，2017，71(2)：154-161.
, 百拇医药
[15]de Torres JP，Marin JM，Casanova C，Cote C，Carrizo S，Cordoba-Lanus E，Baz-Davila R，Zulueta JJ，Aguirre-JaimeA，Saetta M，Cosio MG，Celli BR.Lung cancer in patientswith chronic obstructive pulmonary disease——incidence andpredicting factors.Am J Respir Crit Care Med，2011，184(8)：913-919.
[16]蔡靜静，苗健龙，周金花，张影影，刘瑞娟.慢性阻塞性肺疾病合并肺癌的临床特点分析.临床荟萃，2017，32(12)：1065-1068.
[17]Bozinovski S，Vlahos R，Anthony D，McQualter J，AndersonG，Irving L，Steinfort D.COPD and squamous cell lung cancer：aberrant inflammation and immunity is the common link.Br JPharmacol，2016，173(4)：635-648.
, 百拇医药
[18]Kang HS，Shin AY，Yeo CD，Kim JS，Kim YH，Kim JW，Lee SH.A lower level of forced expiratory volume in one secondpredicts the poor prognosis of small cell lung cancer.J ThoracDis，2018，10(4)：2179-2185.
[19]Shibata Y，Inoue S，Igarashi A，Yamauchi K，Abe S，Aida Y，Nunomiya K、Sato M，Nakano H，Sato K，Nemoto T，Kimura T，Watanabe T，Konta T，Daimon M，Ueno Y，Kato T，Kayama T，Kubota 1.A lower level of forced expiratory volume in 1 secondis a risk factor for all-cause and cardiovascular mortality in aJapanese population：the Takahata study.PLoS One，2013，8(12)：e83725.
, http://www.100md.com
[20]Menezes AM，Perez-Padilla R，Wchrmeister FC，Lopez-VarelaMV，Muino A，Valdivia G，Lisboa C，Jardim JR，de OcaMM，Talamo C，Bielemann R，Gazzotti M，Laurenti R，CelliB，Victora CG：PLATING team.FEV、is a better predictor ofmortality than FVC：the PLATING cohort study.PLoS One，2014，9(10)：e109732.
[21]陈卫军，陈岸，梁兆惺，张继平.肺功能检测在吸烟人群中肺癌筛查的作用.新医学，2013，44(2)：101-104.
(收稿日期：2019-02-04)
(本文编辑：林燕薇)
DOI：10.3969/j.issn.0253-9802.2019.05.012
基金项目：广州市科技计划项目(201604020103)
作者单位：510120 广州，中山大学孙逸仙纪念医院呼吸内科
通信作者，李建国，E-mail：jgli88@126.com, 百拇医药(张学培 李建国)
[12]Hashimoto N，Matsuzaki A，Okada Y，Imai N，Iwano S，WakaiK，Imaizumi K，Yokoi K，Hasegawa Y.Clinical impact ofprevalence and severity of COPD on the decision-making processfor therapeutic management of lung cancer patients.BMC PulmMed，2014，14：14.
, 百拇医药
[13]Omote N，Hashimoto N，Morise M，Sakamoto K，Miyazaki S，Ando A，Nakahara Y，Hasegawa Y.Impact of mild to moderateCOPD on feasibility and prognosis in non-small cell lung cancerpatients who received chemotherapy.Int J Chron ObstructPulmon Dis，2017，12：3541-3547.
[14]Liu S，Zhang M，Yang L，Li Y，Wang L，Huang Z，Wang L，Chen Z，Zhou M.Prevalence and patterns of tobacco smokingamong Chinese adult men and women：findings of the 2010national smoking survey.Epidemiol Community Health，2017，71(2)：154-161.
, 百拇医药
[15]de Torres JP，Marin JM，Casanova C，Cote C，Carrizo S，Cordoba-Lanus E，Baz-Davila R，Zulueta JJ，Aguirre-JaimeA，Saetta M，Cosio MG，Celli BR.Lung cancer in patientswith chronic obstructive pulmonary disease——incidence andpredicting factors.Am J Respir Crit Care Med，2011，184(8)：913-919.
[16]蔡靜静，苗健龙，周金花，张影影，刘瑞娟.慢性阻塞性肺疾病合并肺癌的临床特点分析.临床荟萃，2017，32(12)：1065-1068.
[17]Bozinovski S，Vlahos R，Anthony D，McQualter J，AndersonG，Irving L，Steinfort D.COPD and squamous cell lung cancer：aberrant inflammation and immunity is the common link.Br JPharmacol，2016，173(4)：635-648.
, 百拇医药
[18]Kang HS，Shin AY，Yeo CD，Kim JS，Kim YH，Kim JW，Lee SH.A lower level of forced expiratory volume in one secondpredicts the poor prognosis of small cell lung cancer.J ThoracDis，2018，10(4)：2179-2185.
[19]Shibata Y，Inoue S，Igarashi A，Yamauchi K，Abe S，Aida Y，Nunomiya K、Sato M，Nakano H，Sato K，Nemoto T，Kimura T，Watanabe T，Konta T，Daimon M，Ueno Y，Kato T，Kayama T，Kubota 1.A lower level of forced expiratory volume in 1 secondis a risk factor for all-cause and cardiovascular mortality in aJapanese population：the Takahata study.PLoS One，2013，8(12)：e83725.
, http://www.100md.com
[20]Menezes AM，Perez-Padilla R，Wchrmeister FC，Lopez-VarelaMV，Muino A，Valdivia G，Lisboa C，Jardim JR，de OcaMM，Talamo C，Bielemann R，Gazzotti M，Laurenti R，CelliB，Victora CG：PLATING team.FEV、is a better predictor ofmortality than FVC：the PLATING cohort study.PLoS One，2014，9(10)：e109732.
[21]陈卫军，陈岸，梁兆惺，张继平.肺功能检测在吸烟人群中肺癌筛查的作用.新医学，2013，44(2)：101-104.
(收稿日期：2019-02-04)
(本文编辑：林燕薇)
DOI：10.3969/j.issn.0253-9802.2019.05.012
基金项目：广州市科技计划项目(201604020103)
作者单位：510120 广州，中山大学孙逸仙纪念医院呼吸内科
通信作者，李建国，E-mail：jgli88@126.com, 百拇医药(张学培 李建国)